Mr. Richard A. Goss, M.ED. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 134 Highland Ave, Lewistown, PA 17044 Phone: 717-248-1403 Fax: 717-248-1407 |
Mr. Jerry Edwin Boyer, MA Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 47 Chestnut St, Lewistown, PA 17044 Phone: 717-248-1174 Fax: 717-248-1175 |
Mr. David G Ray, M.ED. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 43 Chestnut St, Lewistown, PA 17044 Phone: 717-248-1766 Fax: 717-248-8551 |
Karen Graham Doberneck, PHD, BCBA-D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 25 N. Main Street, Lewistown, PA 17044 Phone: 717-242-3590 Fax: 717-242-3590 |
Dr. Thomas D Hoefel, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3 W. Monument Sq., Suite 206, Lewistown, PA 17044 Phone: 717-248-8197 Fax: 717-248-6449 |
News Archive
The 30-day window for hospital readmissions - used by the federal government to penalize hospitals believed to provide lower-quality care because patients return to the hospital following discharge - should be reduced to a week or less to more accurately measure factors within a hospital's control, new research from UC Davis has found.
The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.
Public health experts have warned that a severe pandemic has the potential to cripple essential infrastructure and cause a catastrophic collapse of systems. A new study, to be undertaken by the University of New South Wales (UNSW), will assess how prepared Australia really is for a pandemic and identify 'weakest links'.
It is well known that COPD patients run a higher risk of contracting respiratory infections. However, a new thesis from Lund University in Sweden shows that they are also at higher risk of other bacterial infections, such as tuberculosis (TB) and pneumococcal and staphylococcal infections that can cause serious illness.
Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for voclosporin. Lux's NDA, filed in February 2010, seeks approval for voclosporin in the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye.
› Verified 1 days ago